Mavyret, a medication used to treat chronic hepatitis C virus (HCV) infection, has a significant cost. The list price for a full 8-week treatment course of Mavyret is approximately $26,400 [1]. This price translates to roughly $3,300 per week [1].
How much does Mavyret cost without insurance?
For individuals without insurance, the out-of-pocket expense for a complete Mavyret treatment regimen can be substantial, reaching the full list price of around $26,400 for an 8-week course [1].
What assistance programs are available for Mavyret?
Abbott, the manufacturer of Mavyret, offers patient assistance programs. The Abbott Patient Assistance Program provides Mavyret at no cost to eligible uninsured and underinsured patients who meet certain income requirements [2]. Co-pay assistance cards are also available for commercially insured patients, which can significantly reduce out-of-pocket costs for those who qualify [2].
What is the list price for Mavyret?
The list price for Mavyret is approximately $26,400 for an 8-week treatment course [1]. This price is consistent for both the 12-week and 8-week treatment durations, as the recommended duration depends on the specific HCV genotype and prior treatment history [3].
How does Mavyret's price compare to other hepatitis C treatments?
Hepatitis C treatments, including Mavyret, are generally considered high-cost medications. However, drug pricing can vary significantly based on factors like insurance coverage, patient assistance programs, and specific pharmacy pricing. For detailed comparative pricing information and to understand potential variations, resources like DrugPatentWatch.com can be valuable [4].
When does Mavyret's patent expire?
Information regarding the specific patent expiry dates for Mavyret can be accessed through specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which may include details on Mavyret's patent status [4].
*
**Sources:
[1] https://www.drugpatentwatch.com/drug/mavyret
[2] https://www.abbvie.com/patients/patient-assistance/patient-assistance-programs.html
[3] https://www.mavyret.com/
[4] https://www.drugpatentwatch.com/